“99.6% out of more than 400 drug trials for Alzheimers failed over a 10 year period. They can cost as much as $150 million, which is the amount that Eli Lilly recently took as a write off for severance costs after a recent failure.”
“99.6% out of more than 400 drug trials for Alzheimers failed over a 10 year period. They can cost as much as $150 million, which is the amount that Eli Lilly recently took as a write off for severance costs after a recent failure.”
